Steven Cohen Arcturus Therapeutics Holdings Inc. Transaction History

Point72 Asset Management, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$24.35 - $44.39 $2.22 Million - $4.05 Million	-91,224 Reduced 27.2%	244,154 $5.95 Million
Q1 2024 May 15, 2024	BUY	$31.23 - $42.99 $9.92 Million - $13.7 Million	317,800 Added 1807.94%	335,378 $11.3 Million
Q4 2023 Feb 14, 2024	SELL	$17.71 - $32.97 $5.63 Million - $10.5 Million	-317,700 Reduced 94.76%	17,578 $554,000
Q3 2023 Nov 14, 2023	BUY	$25.44 - $37.35 $8.42 Million - $12.4 Million	330,875 Added 7514.76%	335,278 $8.57 Million
Q2 2023 Aug 14, 2023	SELL	$23.94 - $32.36 $1.82 Million - $2.46 Million	-75,985 Reduced 94.52%	4,403 $126,000
Q1 2023 May 15, 2023	BUY	$14.72 - $23.97 $233,871 - $380,835	15,888 Added 24.63%	80,388 $1.93 Million
Q4 2022 Feb 14, 2023	SELL	$14.14 - $23.06 $7.81 Million - $12.7 Million	-552,624 Reduced 89.55%	64,500 $1.09 Million
Q3 2022 Nov 14, 2022	SELL	$13.05 - $22.13 $3.87 Million - $6.55 Million	-296,199 Reduced 32.43%	617,124 $9.15 Million
Q2 2022 Aug 15, 2022	BUY	$12.26 - $31.17 $5.98 Million - $15.2 Million	488,123 Added 114.8%	913,323 $14.4 Million
Q1 2022 May 16, 2022	BUY	$17.64 - $39.57 $7.5 Million - $16.8 Million	425,200 New	425,200 $11.5 Million
Q3 2020 Nov 16, 2020	SELL	$37.49 - $63.19 $8.36 Million - $14.1 Million	-223,013 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $2.82 Million - $13 Million	223,013 New	223,013 $10.4 Million

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $439M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.